186 related articles for article (PubMed ID: 34854264)
1. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
[TBL] [Abstract][Full Text] [Related]
3. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
[TBL] [Abstract][Full Text] [Related]
4. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
[TBL] [Abstract][Full Text] [Related]
6. PK-PD Integration Modeling and Cutoff Value of Florfenicol against
Lei Z; Liu Q; Yang S; Yang B; Khaliq H; Li K; Ahmed S; Sajid A; Zhang B; Chen P; Qiu Y; Cao J; He Q
Front Pharmacol; 2018; 9():2. PubMed ID: 29387013
[TBL] [Abstract][Full Text] [Related]
7. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
[TBL] [Abstract][Full Text] [Related]
8. Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against
Somogyi Z; Mag P; Kovács D; Kerek Á; Szabó P; Makrai L; Jerzsele Á
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057005
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
[TBL] [Abstract][Full Text] [Related]
10. PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against
Huang A; Mao F; Huang L; Xie S; Pan Y; Qu W; Cheng G; Liu Z; Yuan Z; Peng D; Hao H
Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203885
[No Abstract] [Full Text] [Related]
11. PK-PD Analysis of Marbofloxacin against
Lei Z; Liu Q; Yang B; Khaliq H; Cao J; He Q
Front Pharmacol; 2017; 8():856. PubMed ID: 29209222
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals.
Lee DH; Birhanu BT; Lee EB; Lee SJ; Boby N; Park YS; Park SC
Vet Res; 2020 Oct; 51(1):131. PubMed ID: 33059768
[TBL] [Abstract][Full Text] [Related]
13. Impact of an experimental PRRSV and Streptococcus suis coinfection on the pharmacokinetics of ceftiofur hydrochloride after intramuscular injection in pigs.
Day DN; Sparks JW; Karriker LA; Stalder KJ; Wulf LW; Zhang J; Kinyon JM; Stock ML; Gehring R; Wang C; Ellingson J; Coetzee JF
J Vet Pharmacol Ther; 2015 Oct; 38(5):475-81. PubMed ID: 25689130
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics.
Lebel G; Piché F; Frenette M; Gottschalk M; Grenier D
Peptides; 2013 Dec; 50():19-23. PubMed ID: 24096107
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.
Wang J; Hao H; Huang L; Liu Z; Chen D; Yuan Z
Front Microbiol; 2016; 7():36. PubMed ID: 26870006
[TBL] [Abstract][Full Text] [Related]
16. Optimization and Validation of Dosage Regimen for Ceftiofur against
Mi K; Pu S; Hou Y; Sun L; Zhou K; Ma W; Xu X; Huo M; Liu Z; Xie C; Qu W; Huang L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409082
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for
Zhou YF; Peng HM; Bu MX; Liu YH; Sun J; Liao XP
Front Pharmacol; 2017; 8():684. PubMed ID: 29033841
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z
J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
[TBL] [Abstract][Full Text] [Related]
20. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
